View by type:
Documents (9899)
14 Continued funding for special studies presentation pdf
Continued funding for special
studies
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Special studies background
? Funding for special studies provided under the ADIPs:
? Pneumo (US$ 30m) focused on evidence
generation and disease advocacy
? Rota (US$ 50m) included significant phase IV
investment for data to support SAGE
recommendation
? Hib Initiative (US$ 30m) designed to promote Hib
disease burden awareness and conduct studies
including phase IV, impact, etc
? AVI TAC Special Studies ? (US$ 11m) for additional
studies required for pneumococcal and rotavirus
vaccine roll -out
1
Programme update:
Accelerated Vaccine Introduction (AVI)
GAVI Alliance Board Meeting
Washington DC, USA, 12 -13 June 2012
GAVI Alliance Board Meeting
Washington DC, 13 -14 June 2012
AVI update
Rotavirus & Pneumococcal vaccines - status of roll
out & supply
1
AVI TAC
16 Country presentation India pdf
Ministry Of Health & Family Welfare
Govt. of India
An Overview
India?s Universal Immunization Programme
GAVI Alliance Board Meeting
13 June 2012, Washington DC
Presentation outline
Program Progress
Issue & challenges
Initiatives under UIP
Summary
17 GAVI support to Civil Society Organisations presentation pdf
GAVI support to Civil Society
Organisations
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
July 2011 GAVI Board
1
? Slow disbursement of GAVI funds causing
disruption to CSO programme implementation.
? ?Requested the Secretariat, concurrently with the
evaluation of CSO support in 2011, to review
options for direct support to CSOs for service
delivery and advocacy and submit to the PPC for
its recommendation to the Board .?
18 Long term funding strategy presentation pdf
Long -term funding strategy
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Overview
1
? Lessons from first replenishment
? Priorities for long -term funding
? Financing instruments
? Burden sharing directions
? Donor diversification
Overview Reflection Finance Burden share Diversification Guidance
IFFIm report
Ren? Karsenti
Chair , IFFIm Board
David Ferreira
Managing Director for Innovative Finance, GAVI Alliance
GAVI Board Meeting
Washington DC
13 June 2012
International Finance Facility for Immunisation
Significant events in first half of 2012
? S&P downgrade
? Return to capital markets
? IFFIm donor workshop
? Changes to the IFFIm Board
IFFIm report to the GAVI Board
13 June 2012
2
20 IFFIm GFA Restructuring presentation pdf
Debbie Adams
IFFIm/GFA restructuring
GAVI Alliance Board meeting
Washington, DC, USA, 12 ? 13 June 2012
GAVI Alliance Board meeting
12 ?13 June 2012
Background
? Original rationale for GFA no longer relevant
? Removing GFA will have no effect on existing grant
agreements
? Generates savings of up to US$ 1.4 million in direct
costs per year
? IFFIm donors have supported the restructuring
1
21 GAVI Board Decisions 12 13 June 2012 pdf
Review of decisions
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
The GAVI Alliance Board:
? Appointed the following member to the Audit and Finance
Committee effective immediately and until the committees
are refreshed for the 2013 year:
? Yifei Li
Decision 1: Board and Committee member
appointments (1/4)
1
Pneumonia and diarrhoea: Tackling the deadliest diseases for the world’s poorest children
This new report from UNICEF focuses on the huge potential to narrow the child survival gap between the richest and the poorest by focusing on pneumonia and diarrhoea – the two primary killers of children under the age of five.
.......
GAVI Alliance Investment Committee Meeting
24 May 2012
Inv -2012 -Mtg -2 1
GAVI Alliance Investment Committee Meeting
24 May 2012
Teleconference
FINAL MINUTES
1. Chair?s report
1.1 Finding a quorum of members present, the meeting commenced at 9.03
Washington time 24 May 2012 . George W. Wellde, Jr , Investment Committee
Chair , chaired the meeting .
1.2 Standing declarations of interest were tabled to the Committee (Doc 1a in the
Committee pack). The Committee reviewed the minutes of it s meeting on 28
March 2012 (Doc 1b) , noting they had been approved on 1 May 2012. The
Committee also reviewed its action sheet (Doc 1c) and forward workplan (Doc
1d ).
------
2. Portfolio overview
2.1 Jeanne Shen, Chief Investment Officer, highlighted selected matters in the
general capital markets environment and provided an overview of GAVI?s
portfolio (Doc 2).
2.2 Specifically , she commented on the credit quality of the banking sector, and
revisions under consideration by US regulators to regulation s of money
markets funds. She described how GAVI and other potentially affected
organisations may have to adjust to these factors.
2.3 With regard to the portfolio, she reviewed cash, short -term, and long -term
portfolio performance; peer comparisons; contribution t o mission; excess
returns by sector; and individual manager performance and credit quality. She
also reported the total assets under management for each of the portfolio
funds, and commented on one instance in which GAVI assets comprised a
large portion of a particular fund?s assets under management.
2.4 Also, she updated the Committee on the transition of the portfolio to the asset
allocation approved by the Board on 16 -17 November 2011. Finally, she
reported on the Socially Responsible Investing program, noting that the
portfolio was in compliance with established thresholds . However, she
commented that as GAVI added certain assets classes to the portfolio, the